Zacks Research Issues Optimistic Forecast for PAHC Earnings

Phibro Animal Health Co. (NASDAQ:PAHC) – Investment analysts at Zacks Research lifted their Q1 2027 earnings estimates for shares of Phibro Animal Health in a report issued on Tuesday, January 7th. Zacks Research analyst R. Department now expects that the company will post earnings per share of $0.49 for the quarter, up from their prior forecast of $0.47. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.62 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q2 2027 earnings at $0.53 EPS.

A number of other research firms have also weighed in on PAHC. StockNews.com lowered shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday. Morgan Stanley raised their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Tuesday, December 17th. Finally, Barclays upped their price objective on Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a report on Tuesday, November 12th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, Phibro Animal Health presently has an average rating of “Hold” and a consensus price target of $20.50.

Phibro Animal Health Trading Down 6.7 %

PAHC opened at $20.05 on Friday. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. The company’s 50 day simple moving average is $22.75 and its two-hundred day simple moving average is $21.10. Phibro Animal Health has a 1-year low of $10.03 and a 1-year high of $25.98. The firm has a market capitalization of $812.09 million, a price-to-earnings ratio of 46.63, a price-to-earnings-growth ratio of 0.58 and a beta of 0.53.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Quantbot Technologies LP acquired a new position in Phibro Animal Health during the third quarter worth $70,000. nVerses Capital LLC acquired a new position in Phibro Animal Health during the third quarter worth $70,000. China Universal Asset Management Co. Ltd. lifted its stake in Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after purchasing an additional 1,522 shares in the last quarter. CWM LLC lifted its stake in Phibro Animal Health by 190.8% during the third quarter. CWM LLC now owns 6,363 shares of the company’s stock worth $143,000 after purchasing an additional 4,175 shares in the last quarter. Finally, Algert Global LLC acquired a new position in Phibro Animal Health during the second quarter worth $193,000. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th were issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 2.39%. The ex-dividend date was Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio is presently 111.63%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.